"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT03574454","Machine Learning in Myeloma Response","MALIMAR","Recruiting","No Results Available","Myeloma","Other: Machine Learning (ML)","Sensitivity of Machine Learning Algorithm to detect Myeloma|Level of Agreement in Assessment of Disease Burden|Level of Agreement to Classify Disease Spread|Quantification of Improvements to Correctly Identify Disease by Site and Reading Time|Difference in Reading Time with and without Machine Learning|Specificity for Identification of Active Disease with and without Machine Learning|Sensitivity to detect Active Disease in non-Experienced Readers with and without Machine Learning|Agreement in Categorisation of Active Disease|Difference in Reading Time for scoring Disease Burden with and without Machine Learning|Agreement in Categorisation of Disease Responders and non-Responders with Reference Standard|Agreement in Categorisation of Disease Responders and non-Responders in non-Experienced Readers|Agreement in Assessment of Disease Burden in non-Experienced Readers|Difference in Costs of Radiology Reading Time with and without Machine Learning","Royal Marsden NHS Foundation Trust|Institute of Cancer Research, United Kingdom|Imperial College London","All","40 Years to 100 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","CCR 4820|233501|16/68/34","July 4, 2018","May 2021","August 2021","July 2, 2018",,"July 17, 2018","Department of Radiology, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom|Institute of Cancer Research, London, London, United Kingdom|Imperial College, London, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03574454"
2,"NCT02943824","Machine-learning Optimization for Prostate Brachytherapy Planning","MOPP","Completed","No Results Available","Prostatic Neoplasms","Other: Machine Learning Planning|Other: Radiation Therapist Planning","post-operative prostate V100%|Pre-operative planning time|Pre-operative dosimetry|Frequency & magnitude of plan modifications","Sunnybrook Health Sciences Centre","Male","Child, Adult, Older Adult","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","1.1.1","August 24, 2017","August 24, 2018","September 4, 2018","October 25, 2016",,"September 6, 2018","Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02943824"
3,"NCT03706664","Small Bowel Deep Learning Algorithm Project",,"Recruiting","No Results Available","Crohn Disease","Other: Machine learning algorithm","Machine learning algorithm's ability to accurately localize the terminal ileum.|Data processing time until a diagnosis reported by algorithm.|Machine learning algorithm's ability to accurately distinguish abnormal and normal terminal ileum.","London North West Healthcare NHS Trust|Imperial College London","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","226","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRAS No:238924","March 1, 2019","January 2020","September 2020","October 16, 2018",,"August 21, 2019","St Mark's Hospital, London, Harrow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03706664"
4,"NCT03976297","Artificial Intelligence/Machine Learning Modeling on Time to Palliative Care Review in an Inpatient Hospital Population",,"Recruiting","No Results Available","Palliative Care","Other: Control Tower","Timely identification for need of palliative care|The number of inpatient palliative care consults|Timely identification for need of palliative care per unit|Transition time to hospice-designated bed|Time to hospice designation|Emergency Department visit within 30 days of discharge|Hospitalization or readmission within 30 days of discharge|ICU transfers|Ratio of inpatient hospice death to non-hospice hospital deaths|Rate of discharge to external hospice|Inpatient length of stay","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20000","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","19-002315","August 19, 2019","August 19, 2020","October 2020","June 6, 2019",,"August 26, 2019","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03976297"
5,"NCT03711656","Prediction and Prevention of Nocturnal Hypoglycemia in Persons With Type 1 Diabetes Using Machine Learning Techniques",,"Completed","No Results Available","Type1diabetes|Hypoglycemia","Device: isCGM (intermittently scanned Continuous Glucose Monitoring)|Device: Physical exercise tracker","Sensitivity (SE) and specificity (SP) to predict Level 1 hypoglycemia|Sensitivity (SE) and specificity (SP) to predict Level 2 hypoglycemia|Predicted HbA1c from the sensor data|standard deviation (SD)|Mean glucose|Level 3 hypoglycaemia|Percentage of time in hypoglycemic ranges|Percentage of time in target range|Percentage of time in hyperglycemic range >180|Percentage of time in hyperglycemic range >250|Glucose variability LBGI|Glucose variability HBGI|Number of Level 3: severe hypoglycemia","Hospital Clinic of Barcelona|Universitat de Girona","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","Nocturnal Hypoglycemia","October 10, 2018","March 1, 2019","April 30, 2019","October 18, 2018",,"August 7, 2019","Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain",,"https://ClinicalTrials.gov/show/NCT03711656"
6,"NCT03246490","A Machine Learning Approach for Inferring Alcohol Intoxication Levels From Gait Data","Alcogait","Recruiting","No Results Available","Alcohol Drinking","Other: All Participants","Phone App","Butler Hospital","All","21 Years to 75 Years   (Adult, Older Adult)","Not Applicable","250","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","AA025193","December 12, 2017","July 31, 2019","July 31, 2019","August 11, 2017",,"January 4, 2019","Butler Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT03246490"
7,"NCT03053518","Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes",,"Recruiting","No Results Available","Type2 Diabetes","Device: iPro2 CGM with Enlite sensors|Behavioral: LifeStyle","Observed incremental area under the curve (iAUCobs)","NYU Langone Health","All","21 Years to 70 Years   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","16-01059","June 30, 2017","December 2019","December 2019","February 15, 2017",,"October 25, 2018","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03053518"
8,"NCT02960386","An Engagement Engine for Fitness Trackers","iTrackFitnes","Active, not recruiting","No Results Available","Overweight|Obese","Other: Machine Learning Algorithm","Engagement level with the tracker|Change in Physical Activity|Change in Self-efficacy scale for Physical Activity|Change in Barriers to Being Active Questionnaire","Massachusetts General Hospital|Robert Wood Johnson Foundation","All","18 Years to 95 Years   (Adult, Older Adult)","Not Applicable","138","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","2016P001506","January 2016","April 2018","December 2018","November 9, 2016",,"August 15, 2018","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02960386"
9,"NCT03582501","Measurement of Hemodynamic Responses to Lower Body Negative Pressure","LBNP","Completed","No Results Available","Hypotension and Shock","Other: Lower body negative pressure","Blood pressure|Heart rate","Mayo Clinic","All","18 Years to 55 Years   (Adult)","Not Applicable","24","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","18-002695","January 8, 2019","May 23, 2019","May 23, 2019","July 11, 2018",,"June 12, 2019","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03582501"
10,"NCT03633825","Brief Online Help-seeking Barrier Reduction Intervention",,"Completed","Has Results","Crisis Intervention|Suicide and Depression","Behavioral: Brief help-seeking barrier reduction intervention","Number of Participants Reporting Use of Crisis-referrals|Number of Participants in the Treatment Versus Control Conditions Reporting Their Experience Using Koko Was ""Good""","Harvard University","All","Child, Adult, Older Adult","Not Applicable","39450","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","IRB17-1303","August 10, 2017","September 20, 2017","September 20, 2017","August 16, 2018","April 17, 2019","August 12, 2019","Harvard University, Cambridge, Massachusetts, United States","""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT03633825/SAP_000.pdf|""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT03633825/Prot_001.pdf","https://ClinicalTrials.gov/show/NCT03633825"
11,"NCT03655626","Implementation and Evaluations of Sepsis Watch",,"Completed","No Results Available","Sepsis|Severe Sepsis|Septic Shock","Other: Sepsis Watch","Rate of Centers for Medicare and Medicaid Services (CMS) bundle completion for patients with sepsis|Mean time from ED arrival to sepsis for patients with sepsis|Average number of patients who develop sepsis per day and month|Average number of patients who develop sepsis and are not treated per day and month|Mean ED length of stay for patients with sepsis|Mean Hospital length of stay for patients with sepsis|Mean Inpatient mortality for patients with sepsis|Mean ICU requirement rate for patients with sepsis|Mean time from sepsis onset to blood culture|Mean time from sepsis onset to antibiotics|Mean time from sepsis onset to IV fluids|Mean time from sepsis onset to lactate|Mean time from sepsis onset to CMS bundle completion|Rate of lactate complete for patients with sepsis|Number of sepsis diagnosis codes across Duke University Hospital patients per month","Duke University|Data & Society Research Institute|Duke Clinical Research Institute","All","18 Years and older   (Adult, Older Adult)","Not Applicable","32003","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Pro00093721","November 5, 2018","July 5, 2019","July 5, 2019","August 31, 2018",,"August 1, 2019","Duke University Hospital, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03655626"
12,"NCT01608438","Motor Learning in a Customized Body-Machine Interface","BMI","Recruiting","No Results Available","Spinal Cord Injury","Device: Customizing the Body-Machine Interface","Change in Time to task completion from Baseline at 8 months|Change in Movement Smoothness from Baseline at 8 months|Change in Strength|Change in Mental State","Shirley Ryan AbilityLab|National Institutes of Health (NIH)","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","46","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","STU00057856","February 2013","March 2019","March 2019","May 31, 2012",,"September 11, 2018","Shirley Ryan AbilityLab, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01608438"
13,"NCT03946319","Personalized, Transdiagnostic Approach to Preventative Mental Health",,"Recruiting","No Results Available","Mental Health|Mental Disorders|Delivery of Health Care|Self-Assessment|Diagnosis, Psychiatric","Diagnostic Test: Introspect Health","Self-Report Adherence Rate|Completed Assessments Scored|Assessment Questions Scored|Time per Assessment Question|Response Time|Assessment Completion Rate","Introspect Health","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","IH-001","May 2019","August 2019","August 2019","May 10, 2019",,"May 14, 2019","California Institute of Integral Studies, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT03946319"
14,"NCT02651493","Digital Dysmorphology Project",,"Recruiting","No Results Available","Down Syndrome","Device: photographs","Number of participants with Down syndrome accurately assessed by computer-aided detection (CADe) tool|Number of participants with other dysmorphic syndromes accurately assessed by computer-aided detection (CADe) tool","Kevin Cleary|Children's Research Institute|George Washington University|Chiang Mai University","All","up to 18 Years   (Child, Adult)","Not Applicable","750","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","Pro00003506.","February 2013","December 2023","December 2023","January 11, 2016",,"January 4, 2019","Children's National, Washington, District of Columbia, United States",,"https://ClinicalTrials.gov/show/NCT02651493"
15,"NCT04026555","Realtime Streaming Clinical Use Engine for Medical Escalation","ReSCUE-ME","Recruiting","No Results Available","Clinical Deterioration|Hospital Medicine|Monitoring, Physiologic","Other: MEWS++ Monitoring|Other: Predictor Score","Overall rate of care escalation|Number of participants requiring blood pressure support|Number of participants requiring respiratory support|Number of cardiac arrest episode|Mortality Rate|Notification Frequency|Number of calls|Sensitivity and Specificity of the RRT alert","Icahn School of Medicine at Mount Sinai","All","18 Years and older   (Adult, Older Adult)","Not Applicable","18680","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","GCO 19-0729","June 18, 2019","June 30, 2020","June 30, 2020","July 19, 2019",,"July 19, 2019","Mount Sinai Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04026555"
16,"NCT03982654","Investigating the Physiology of Labour and Labour Onset Through Longitudinal Measurements Performed With a Wearable Sensor",,"Completed","No Results Available","Labour Onset","Device: Bloomlife","Accuracy|Labour probability","Bloom Technologies","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","145","Industry","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","WISH01","March 30, 2018","November 26, 2018","March 5, 2019","June 11, 2019",,"June 11, 2019","Ziekenhuis Oost-Limburg, Genk, Belgium|CHR de la Citadelle, Liège, Belgium",,"https://ClinicalTrials.gov/show/NCT03982654"
17,"NCT04035993","The HEADWIND-Study","HEADWIND","Recruiting","No Results Available","Diabetes|Diabetes Mellitus, Type 1","Other: Controlled hypoglycaemic state while driving with a driving simulator","Accuracy of the HEADWIND-model: Diagnostic accuracy of the hypoglycaemia warning system (HEADWIND) to detect hypoglycaemia (blood glucose < 3.9 mmol/l) quantified as the area under the receiver operator characteristics curve (AUC ROC > 0.85).|Change of time driving over midline|Change of swerving|Change of spinning|Defining the glycemic level when driving performance is decreased|Driving performance before and after hypoglycemia|Change of heart-rate|Change of heart-rate variability|Change of electrodermal activity (EDA)|Change of skin temperature|CGM accuracy during hypoglycaemic state|CGM time-delay during hypoglycaemic state|Change of glucagon|Change of growth hormone (GH)|Change of catecholamines|Change of cortisol|Glycemic level at time point of hypoglycemia detection by the HEADWIND-model|Comparison CGM and HEADWIND-model regarding time-point of hypoglycemia detection|Comparison CGM and HEADWIND-model regarding glycemia|Accuracy-comparison of HEADWIND-model and HEADWINDplus-model|Self-estimation of glucose and hypoglycemia|Self-estimation of driving performance|Time point of need-to-treat|Self-perception of hypoglycemia symptoms compared to baseline hypoglycemia awareness|Incidence of Adverse Events (AEs)|Incidence of Serious Adverse Events (SAEs)|Perceived ease of use of the early hypoglycaemia warning system (EWS)|Perceived usefulness of the EWS|Perceived enjoyment during EWS usage|Intention to adopt the EWS|Intention to continuously use the EWS|Reception of recommendations of the EWS|Processing of recommendations of the EWS|Perceived understandability of the recommendations of the EWS|Perceived familiarity of the recommendations of the EWS|Cognitive and emotional trust in the recommendations of the EWS","University Hospital Inselspital, Berne|University of Zurich|University of St.Gallen","All","21 Years to 50 Years   (Adult)","Not Applicable","25","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","HEADWIND","October 1, 2019","July 31, 2020","July 31, 2020","July 29, 2019",,"September 5, 2019","University Department of Endocirnology, Diabetology, Clinical Nutrition and Metabolism, Bern, Switzerland",,"https://ClinicalTrials.gov/show/NCT04035993"
18,"NCT03739073","Can we Predict COronary Resistance By EYE Examination ? (COREYE)","COREYE","Recruiting","No Results Available","Coronary Artery Disease","Other: OCTA (angiography by tomography in optical coherence)","Coronary microvascular resistance results (Combowire)|Coronary microvascular resistance results (OCTA)|angiographical stenosis|Fractional Flow Reserve (FFR)|coronary microvascular resistance (CFR)|microvascular resistance values|total area of flow signal void on the choriocapillaris layer","Hospices Civils de Lyon","All","18 Years and older   (Adult, Older Adult)","Not Applicable","210","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","69HCL18_0301|2018-A01181-54","October 4, 2018","April 5, 2020","April 5, 2021","November 12, 2018",,"December 31, 2018","Hospices Civils de Lyon - Hopital de la Croix Rousse, Lyon, France",,"https://ClinicalTrials.gov/show/NCT03739073"
19,"NCT03643692","Adaptive, Real-time, Intelligent System to Enhance Self-care of Chronic Disease","ARISES","Recruiting","No Results Available","Diabetes Mellitus, Type 1","Device: ARISES","Usability Questionnaire","Imperial College London","All","18 Years and older   (Adult, Older Adult)","Not Applicable","12","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","18HH4410","February 26, 2019","August 2020","August 2020","August 23, 2018",,"June 28, 2019","Imperial College Clinical Research Facility, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03643692"
20,"NCT03804606","Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure",,"Enrolling by invitation","No Results Available","Heart Failure","Other: Referral to MTM Pharmacist","All-cause mortality|Hospital admission|Healthcare utilization - Total cost of care|Incidence of flu vaccine care gap closure; relationship to mortality|Incidence of evidence-based beta blocker care gap closure; relationship to mortality|Incidence of ACE inhibitor/ARB care gap closure; relationship to mortality|Incidence of diabetic a1C ""in goal"" care gap closure; relationship to mortality","Geisinger Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","2018-0735","February 28, 2019","June 2020","June 2020","January 15, 2019",,"April 9, 2019","Geisinger Health System, Danville, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03804606"
21,"NCT02265354","Developing Smokers for Smoker (S4S): A Collective Intelligence Tailoring System","S4S","Active, not recruiting","No Results Available","Tobacco Smoking","Behavioral: Collective-Intelligence computer tailored health communication|Behavioral: Rule-based computer tailored health communication","Repeated Use of website measure|30-day point prevalent smoking cessation at six months","University of Massachusetts, Worcester|University of Massachusetts, Amherst|National Cancer Institute (NCI)","All","19 Years and older   (Adult, Older Adult)","Not Applicable","260","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","H00002005|K07CA172677","January 11, 2017","October 2019","August 2020","October 15, 2014",,"July 15, 2019","UMass Medical School, Worcester, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02265354"
22,"NCT03984773","Machine-Generated Mortality Estimates and Nudges to Promote Advance Care Planning Discussion Among Cancer Patients",,"Enrolling by invitation","No Results Available","Oncology","Behavioral: Nudge","Change in the proportion of patients with a documented serious illness conversation (SIC)|Change in the proportion of patients with a documented SIC among those identified as high-risk by the algorithm|Change in the proportion of patients with a documented advanced care planning|Change in the proportion of patients with a documented serious illness conversation (SIC) including follow-up|Change in the proportion of patients with a documented SIC among those identified as high-risk by the algorithm including follow-up|Change in the proportion of patients with a documented advanced care planning including follow-up","University of Pennsylvania","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","833178","July 15, 2019","November 2019","May 2020","June 13, 2019",,"July 16, 2019","Penn Medicine, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03984773"
23,"NCT03547219","Biomarkers of Antidepressant Response and Suicidal Events in Depressed Youth",,"Completed","No Results Available","Depression|Adolescent","Drug: Escitalopram","the change from baseline in CDRS-R at week 8 or upon termination|CGI-I at 8 weeks or upon termination","Seoul National University|National Research Foundation of Korea","All","12 Years to 17 Years   (Child)","Not Applicable","152","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015R1A2A2A01004501","August 5, 2015","August 2, 2018","August 2, 2018","June 6, 2018",,"April 4, 2019","Seoul National University Hospital, Seoul, N/A = Not Applicable, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT03547219"
24,"NCT03607435","A Clinical Study to Collect Calibration & Performance Data of the KBS Systems 1.0 Non-Invasive Glucose Monitoring Device",,"Recruiting","No Results Available","Diabetes","Device: Spectroscopy for Analyte Quantification","Calibration of the KBS-1 Test Article using the POC Control data for comparison.|Research Subject Assessment|Calibration of the RBA-1 Test Article using the hospital lab test Control data and POC blood glucose monitor Control data for comparison.","Florida Hospital Tampa Bay Division|Kaligia Biosciences LLC","All","21 Years and older   (Adult, Older Adult)","Not Applicable","300","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","KBS002","August 2, 2018","June 2019","July 2019","July 31, 2018",,"August 6, 2018","Florida Hospital Tampa, Tampa, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03607435"
25,"NCT02734875","Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology","IQ-MATCH","Completed","No Results Available","Atrial Fibrillation","Other: Intervention","Anticoagulation therapy","Brigham and Women's Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","432","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other","2015P000893/BWH","May 2016","August 2017","August 2017","April 12, 2016",,"January 16, 2019",,,"https://ClinicalTrials.gov/show/NCT02734875"
26,"NCT02176226","IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)",,"Completed","Has Results","Major Depressive Disorder|Anxiety Disorders","Behavioral: IntelliCare","Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module|GAD-7 (Generalized Anxiety Disorder Scale-7)|Mean Number of Treatment App Use Sessions by Study Week","Northwestern University","All","19 Years and older   (Adult, Older Adult)","Not Applicable","105","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH100482-01FTIC","March 2015","June 2016","June 2016","June 27, 2014","October 29, 2018","October 29, 2018","Northwestern University, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02176226"
27,"NCT03960203","Effect of a Sepsis Prediction Algorithm on Clinical Outcomes",,"Completed","No Results Available","Severe Sepsis","Diagnostic Test: InSight","In-hospital mortality|Hospital length of stay|30-day readmissions","Dascena","All","18 Years and older   (Adult, Older Adult)","Not Applicable","75147","Industry","Interventional","Masking: None (Open Label)|Primary Purpose: Diagnostic","05172019","January 2017","June 2018","June 2018","May 22, 2019",,"May 24, 2019",,,"https://ClinicalTrials.gov/show/NCT03960203"
28,"NCT02801877","IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression","AIM","Completed","Has Results","Depression|Anxiety","Behavioral: IntelliCare|Behavioral: Hub App with the Recommender System|Behavioral: Coaching","Adherence to the Mobile Application Intervention|Depression Severity|Anxiety Severity","Northwestern University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","301","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH100482-01-RCTIC|R01MH100482-01","July 2016","January 2018","January 2018","June 16, 2016","May 31, 2019","May 31, 2019","Northwestern University, Chicago, Illinois, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/77/NCT02801877/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02801877"
29,"NCT03788915","Weight Loss and Reversing T2D Through eHealth Coaching","LIVA","Recruiting","No Results Available","Obesity","Behavioral: Online dietetic lifestyle counseling|Behavioral: Usual care","Weight change|HbA1C change","University of Southern Denmark|Odense University Hospital","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","340","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","LIVA USouthernDenmark","April 16, 2018","April 2019","March 2021","December 28, 2018",,"December 28, 2018","Research Unit for General Practice, Department for Public Health, University of Southern Denmark, Odense, Region Of Southern Denmark, Denmark|Lægehuset i Stenstrup, Stenstrup, Denmark",,"https://ClinicalTrials.gov/show/NCT03788915"
30,"NCT02499094","Modeling and Predicting Real World Behavior Using Mobile Sensor Data on Patients With Major Depressive Disorder",,"Completed","No Results Available","Depressive Disorder","Other: Behavioral-data driven support","Change in depression symptom severity|Change in patient activation","Ginger.io","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","1004","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","GIO-001","December 2014","July 2015",,"July 15, 2015",,"July 15, 2015",,,"https://ClinicalTrials.gov/show/NCT02499094"
31,"NCT03962426","Efficacy of Social Cognitive Training (SCT) in Recent-onset Psychosis",,"Recruiting","No Results Available","Psychosis","Device: SocialVille Social Cognitive Training","Global cognition|Neural effects- Blood Oxygenation Level Dependent (BOLD) images|Decision scores of the ROP-HC classifier|Global functioning - Social (GF-S) and Role (GF-R)|Global Assessment of Functioning (GAF)|Positive and Negative Syndrome Scale (PANSS)|Cognitive Domain - Social Cognition (SC)|Cognitive Domain - Speed of Processing (SoP)|Cognitive Domain - Working Memory (WM)|Cognitive Domain - Verbal Learning (VL)|Cognitive Domain - Attention (Attn)|Cognitive Domain - Executive Functioning (EF)","Ludwig-Maximilians - University of Munich|Posit Science Corporation","All","15 Years to 40 Years   (Child, Adult)","Not Applicable","66","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","972_961_PNKT_LKI","May 2016","August 31, 2019","August 31, 2019","May 24, 2019",,"June 6, 2019","LudwigMaximilians, München, Deutschland, Germany",,"https://ClinicalTrials.gov/show/NCT03962426"
32,"NCT03946618","Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy",,"Recruiting","No Results Available","Epilepsy","Device: Medtronic Summit System, Olympus","Adverse events (AE) experienced with the RC+S system|24/7 continuous iEEG monitoring|Change in mood|Change in anxiety|Tracking cognition","Mayo Clinic|National Institute of Neurological Disorders and Stroke (NINDS)|Medtronic","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 1","10","Other|NIH|Industry","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-005483|UH2NS095495-03","July 10, 2019","April 30, 2022","December 31, 2022","May 10, 2019",,"June 11, 2019","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03946618"
33,"NCT03916562","Optimization Principles in Hemiparetic Gait",,"Recruiting","No Results Available","Stroke","Behavioral: Manipulation of spatiotemporal coordination during walking","Oxygen consumption (VO2)|Correlation between oxygen consumption (VO2) and step length asymmetry|Angular momentum during walking|Correlation between angular momentum and step length asymmetry during walking","University of Southern California|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","108","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HS-18-00533|R01HD091184","November 13, 2018","May 31, 2022","May 31, 2022","April 16, 2019",,"April 16, 2019","University of Southern California, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03916562"
34,"NCT03956004","The Impact of a Technology-enabled Decision Aid, for Patients With Hip and Knee Osteoarthritis on Decision Quality, Level of Shared Decision-making, Patient Satisfaction and Magnitude of Limitations",,"Recruiting","No Results Available","Osteoarthritis, Knee","Other: OM1 Dell Shared Decision Making Tool|Other: Education material from OM1 Dell Shared Decision Making Tool","Knee Osteoarthritis Decision Quality Instrument|CollaboRATE|Numeric rating scale-satisfaction|Knee injury and osteoarthritis outcome score, joint replacement (KOOS JR)|Undergoing joint replacement surgery or not|Average time of patient visit and average time spent with provider","University of Texas at Austin","All","45 Years to 89 Years   (Adult, Older Adult)","Not Applicable","250","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","2018-11-0042","March 28, 2019","June 2020","June 2020","May 20, 2019",,"May 20, 2019","UT Health Austin, Austin, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03956004"
35,"NCT03923699","Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety","TECTONICS","Recruiting","No Results Available","Surgery|Surgery--Complications|Perioperative/Postoperative Complications","Device: Anesthesia Control Tower monitoring","Number of Participants with clinically relevant adverse perioperative outcomes.|Thirty-day postoperative mortality|Unintended intraoperative awareness|Postoperative delirium|Postoperative respiratory failure|Postoperative acute kidney injury","Washington University School of Medicine|National Institute of Nursing Research (NINR)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40000","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other","201903026|R01NR017916","July 1, 2019","July 2024","July 2024","April 23, 2019",,"July 17, 2019","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT03923699"
36,"NCT02155075","Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System",,"Recruiting","No Results Available","Breast Cancer","Device: MIRA device imaging","Sufficient number of cancer case and controls have been imaged","Real Imaging Ltd.","Female","30 Years and older   (Adult, Older Adult)","Not Applicable","730","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","960-CSP-ISR_ImplantsMC_ILS3","January 2015","October 2019","October 2019","June 4, 2014",,"June 19, 2018","The Chaim Sheba Medical Center at Tel Hashomer, Ramat-Gan, Israel",,"https://ClinicalTrials.gov/show/NCT02155075"
37,"NCT03495180","Quantitative SSEP and EEG as Objective Pain Biomarker",,"Recruiting","No Results Available","Pain","Other: Standard EEG or SSEP","Correlation of (electrical) pain intensity (X) and amplitude of SSEP (Y).","University of Alabama at Birmingham","All","19 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","67890123","May 22, 2018","November 1, 2019","November 1, 2020","April 11, 2018",,"July 4, 2019","University of Alabama at Birmingham, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT03495180"
38,"NCT02747940","Neurologic Signatures of Chronic Pain Disorders",,"Recruiting","No Results Available","Chronic Pain|Chronic Migraine|Fibromyalgia","Drug: flunarizine and/or pregabalin","clinical improvement after treatment (1) headache/pain intensity [NRS, numeric rating scale]|clinical improvement after treatment (2) headache/pain frequency [attacks per month]|clinical improvement after treatment (3) headache/pain duration [hours per day]|EEG change after treatment|sensory and pain threshold change after treatment|Autonomic function change after treatment","Taipei Veterans General Hospital, Taiwan|Ministry of Science and Technology, R.O.C.","All","20 Years to 70 Years   (Adult, Older Adult)","Phase 4","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015-10-001BC2015-11-001AC002B","December 2015","December 2019",,"April 22, 2016",,"April 22, 2016","Headache Center, Teipei Veterans General Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT02747940"
39,"NCT03832192","Care.Coach Avatars for Improvement of Outcomes in Hospitalized Elders, Including Mitigation of Falls and Delirium: a Multi-Site Clinical Study","AvatarHELP","Recruiting","No Results Available","Delirium|Fall Injury","Behavioral: care.coach Avatar (HELP-Protocolized)","Incident Delirium|Falls|Delirium Resolution|Change in Delirium Severity|Patient Sitter Utilization|Change in Cognitive Function|Falls with Injury","Victor Wang|National Institute of Nursing Research (NINR)|Prisma Health-Midlands|Pace University|care.coach corporation","All","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","7000","Industry|NIH|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","1R44NR017842-02","January 8, 2019","January 7, 2021","January 7, 2021","February 6, 2019",,"February 6, 2019","Jamaica Hospital Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03832192"
40,"NCT03651700","Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia",,"Recruiting","No Results Available","Aphasia","Device: Active TMS|Device: Sham TMS|Behavioral: CILT","Change in WAB-AQ|Change in PNT","H. Branch Coslett|National Institutes of Health (NIH)|National Institute on Deafness and Other Communication Disorders (NIDCD)|University of Pennsylvania","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","83","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","chbdfejh|R01DC016800","March 28, 2019","June 30, 2023","June 30, 2023","August 29, 2018",,"April 5, 2019","University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03651700"
41,"NCT01912118","The Medasense Study",,"Completed","No Results Available","Pain","Drug: Propofol|Drug: Remifentanil","Nociception level index (NoI)|Cardiovascular parameters|Movement|Depth of anesthesia","Leiden University Medical Center|Medasense Biometrics Ltd","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","96","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","NL43511.058.13","July 2013","June 2014","September 2014","July 30, 2013",,"April 6, 2015","Leiden University Medical Center, Leiden, Netherlands",,"https://ClinicalTrials.gov/show/NCT01912118"
42,"NCT03065829","Self-Management Behaviors of Caregivers of the Chronically Critically Ill","ASSIST","Completed","No Results Available","Critical Illness","Behavioral: ASSIST|Behavioral: Attention-Control","Repeated Measures|Change in Active Living Protocol (captured on wearable device)|Change in Daily Diary of Physical Activity (captured on wearable device)|Change in Perceived Stress Scale|Change in PROMIS-29 Scale|Change in Zarits Burden Interview|Change in Health Behaviors Questionnaire|Change in Heart Rate Variability (captured on wearable device)","Case Western Reserve University|National Institutes of Health (NIH)|National Institute of Nursing Research (NINR)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","19","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care","11-15-11|P30NR015326","February 2016","July 31, 2017","July 31, 2017","February 28, 2017",,"July 10, 2018","University Hospitals Case Medical Center, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03065829"
43,"NCT03991637","Non-Invasive Blood Test Cross-Validation Study",,"Completed","No Results Available","Reproducibility of Results|Safety Issues","Device: Non-Invasive Comprehensive Metabolic Panel","Performance of Non-Invasive Comprehensive Metabolic Panel","Joseph Allen Jr.|University of North Dakota|Concord Medical Technology Corporation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB-201807-004","July 18, 2018","September 11, 2018","March 1, 2019","June 19, 2019",,"June 24, 2019","Altru Health System, Grand Forks, North Dakota, United States",,"https://ClinicalTrials.gov/show/NCT03991637"
44,"NCT03453554","Evaluating a Digital Memory Notebook App to Improve Functional Independence",,"Recruiting","No Results Available","Mild Cognitive Impairment","Other: Digital Notebook app|Other: Smart Home Prompting","Digital Memory Notebook Use|Quality of Life|Activities of Daily Living|Caregiver Burden|Coping self-efficacy|Cognitive functioning","Washington State University|United States Department of Defense","All","40 Years and older   (Adult, Older Adult)","Not Applicable","30","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","AZ150096","August 1, 2018","August 30, 2021","August 30, 2021","March 5, 2018",,"October 8, 2018","Washington State University - Pullman, Pullman, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03453554"
45,"NCT03208400","Virtual Reality Exposure in Spider Phobia",,"Recruiting","No Results Available","Specific Phobia|Cognitive-behavioral Therapy|Virtual Reality","Behavioral: virtual reality exposure","Spider Phobia Questionnaire (SPQ)|Behavioral Avoidance Text (BAT)|Clinical Global Impressions (CGI)","Julius-Maximilians University|University Hospital Muenster","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Spider_VR","September 1, 2017","August 31, 2019","February 28, 2020","July 5, 2017",,"August 8, 2018","Center of Mental Health, Dept. of Psychiatry, Psychosomatics, and Psychiatry, University Hospital of Wuerzburg, Wuerzburg, Bavaria, Germany|Dept. of Psychiatry, University Hospital Münster, Münster, North Rhine-Westphalia, Germany",,"https://ClinicalTrials.gov/show/NCT03208400"
46,"NCT03424681","Modafinil for the Treatment of Alcohol Use Disorders",,"Recruiting","No Results Available","Alcohol Use Disorder","Drug: Modafinil|Other: Placebo","Time to relapse|drinks per drinking day|drinks per week|percent days abstinent","The Mind Research Network","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","24","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","FP00002746","December 11, 2017","December 31, 2019","December 31, 2019","February 7, 2018",,"March 16, 2018","Mind Research Network, Albuquerque, New Mexico, United States",,"https://ClinicalTrials.gov/show/NCT03424681"
47,"NCT03808428","CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot",,"Recruiting","No Results Available","Stroke","Device: Ankle Group","Fugl-Meyer Assessment Lower Extremity (FMA-LE)|Functional Ambulation Classification (FAC)|Modified Ashworth Scale (MAS)|Berg Balance Scale (BBS)|Timed 10-Meter Walk Test (10MWT)|6 Minute Walk Test (6MWT)","Chinese University of Hong Kong|The Hong Kong Jockey Club Charities Trust","All","18 Years and older   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2018.493","February 1, 2019","December 31, 2021","December 31, 2021","January 17, 2019",,"January 17, 2019","Department of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03808428"
48,"NCT01317628","Effects of Tobacco Smoke Exposure on Epigenetic Signatures and Immunotoxicological Reactions",,"Completed","No Results Available","The Study Focused on Reducing Tobacco Smoke Exposure for Child.","Behavioral: Tobacco smoke reduction trial intervention program","Change from Baseline in cotinine level at 3 months|Change from Baseline in smoking status at 3 months|Change from Baseline in DNA methylation at 3 months|Change from Baseline in immunological cytokine at 3 months|Change from Baseline in miRNA expression at 3 months|Change from Baseline in immunological function at 3 months","National Taiwan University Hospital","All","12 Years to 16 Years   (Child)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","201009040R","April 2011","June 2011","June 2011","March 17, 2011",,"October 29, 2013",,,"https://ClinicalTrials.gov/show/NCT01317628"
49,"NCT03594760","PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer",,"Recruiting","No Results Available","Prostate Cancer","Diagnostic Test: 18F-DCFPyL IV injection","Overall survival|Progression free survival","Centre hospitalier de l'Université de Montréal (CHUM)","Male","18 Years and older   (Adult, Older Adult)","Phase 3","1000","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","18.068","December 1, 2018","December 2023","December 2024","July 20, 2018",,"January 31, 2019","Centre Hospitalier de l'université de Montréal, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03594760"
50,"NCT03217383","Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy",,"Active, not recruiting","No Results Available","Sleep Apnea|Sleep Apnea, Obstructive|Sleep Disordered Breathing","Device: MATRx plus","Sensitivity|Oral appliance compliance|Usability","Zephyr Sleep Technologies","All","21 Years to 80 Years   (Adult, Older Adult)","Not Applicable","61","Industry","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","ZCP201703","July 10, 2017","September 30, 2019","December 31, 2019","July 14, 2017",,"April 18, 2019","Zephyr Sleep Technologies, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03217383"
51,"NCT03826290","Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record",,"Recruiting","No Results Available","Diabetes Mellitus|Diabetes Mellitus, Type 2","Other: EHR-integrated diabetes dashboard","Per-patient change in Hemoglobin A1c (HbA1c) levels from beginning to end of evaluation period|Per-patient change in body mass index (BMI) from beginning to end of evaluation period|Cost of diabetes medications prescribed","University of Utah|Hitachi, Ltd.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","17000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","UUtah_00109162","January 9, 2019","January 2020","May 2020","February 1, 2019",,"February 1, 2019","University of Utah Health, Salt Lake City, Utah, United States",,"https://ClinicalTrials.gov/show/NCT03826290"
52,"NCT03625271","The Canadian Armed Forces PEER Study","PEERCanada","Recruiting","No Results Available","Depression|Non-psychotic Diagnosis as Co-morbidity","Device: The PEER Report","Quick Inventory of Depressive Symptomatology - Self Report 16 Item Questionnaire|CHRT-7SR:|PCL-M/C - if applicable:|Patient-recorded CGI-I (Clinical Global Impressions-Improvement)|Physician-recorded CGI-I (Clinical Global Impressions-Improvement)|CGI-S (Clinical Global Impressions - Severity) - Physician|HAM-D (Hamilton Rating Scale for Depression):","CNS Response|University of Ottawa|Canadian Forces Health Services Centre Ottawa","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","150","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","CNS013","June 16, 2016","July 1, 2019","December 1, 2019","August 10, 2018",,"July 10, 2019","The Royal Mental Health Center, Ottawa, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03625271"
53,"NCT01465087","Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples",,"Completed","No Results Available","Multiple Sclerosis","Other: NA-NOSE artificial olfactory system","Volatile organic compounds in the exhaled breath|Markers in exhaled breath","Carmel Medical Center|Technion, Israel Institute of Technology","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","314","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CMC-11-0083-CTIL|Nano-MS-2011","December 2011","February 2014","January 2015","November 4, 2011",,"June 28, 2016","Multiple Sclerosis Clinic, Carmel Medical Center, Haifa, Israel",,"https://ClinicalTrials.gov/show/NCT01465087"
54,"NCT04087564","The Impact of Music on Nociceptive Processing",,"Recruiting","No Results Available","Pain, Acute|Pain, Chronic|Anxiety|Anxiety Disorders|Catastrophization|Healthy","Other: music intervention","Modulation of Pressure Pain Threshold/Tolerance|Modulation of Temporal Summation with Repeated Pinpricks|Modulation of Temporal Summation with Pressure Cuff|Modulation of Heat Pain Threshold and Tolerance|Modulation of Heat Offset Analgesia|Modulation of Conditioned Pain Modulation|Modulation of Anxiety","Brigham and Women's Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","210","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2019P000824","June 13, 2019","June 1, 2021","July 1, 2022","September 12, 2019",,"September 12, 2019","Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04087564"
55,"NCT03746392","Project to Improve Communication About Serious Illness - Pilot Study","PICSI-P","Recruiting","No Results Available","Malignant Neoplasm|Leukemia, Lymphocytic, Chronic, B-Cell|Lung Disease Chronic|Congestive Heart Failure|Liver Failures, Chronic|Renal Insufficiency, Chronic|Dementia|Diabetes Complications|Peripheral Vascular Disease|Frail Elderly","Behavioral: Jumpstart Intervention","Documentation of goals of care","University of Washington","All","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","STUDY00004821","July 1, 2018","March 31, 2020","June 30, 2020","November 19, 2018",,"September 4, 2019","Harborview Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03746392"
56,"NCT03692247","The Impact of Music Therapy on Nociceptive Processing",,"Completed","No Results Available","Pain|Chronic Pain","Other: Smartphone-based Music Intervention","Changes in Pain Sensitivity in the Presence of Music","Brigham and Women's Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","2017P002872","June 7, 2018","July 18, 2018","July 18, 2018","October 2, 2018",,"January 30, 2019","Brigham and Women's Hospital, Brookline, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03692247"
57,"NCT02843529","Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (Altoida™)","AltoidaML","Enrolling by invitation","No Results Available","Alzheimer Disease|Mild Cognitive Impairment|Memory Disorders|Cognitive Impairment|Dementia|Presymptomatic Disease","Other: Altoida: neuropsychological, EEG and CSF biomarkers","Change in sensitivity , specificity and accuracy of Altoida models|Change from Baseline in Clinical Measure 1|Change from Baseline in Clinical Measure 2|Change from Baseline in Clinical Measure 3|Change from Baseline in Clinical Measure 4|Change from Baseline in Clinical Measure 5|Change from Baseline in Clinical Measure 6|Change from Baseline in Clinical Measure 7|Change from Baseline in Cognitive Measure|Secondary resting state EEG endpoints|Secondary resting state auditory oddball ERP endpoints|Total Abeta 1-42 (Aβ42) amyloid deposition|Change of brain amyloid deposition|Change of CSF biomarkers tau and ptau181 values|MRI (Optional)|Changes in Driving breaking force|Changes in Driving acceleration velocity|Changes in Driving direction|Changes in driving violations","Altoida|Greek Alzheimer's Association and Related Disorders|University of Roma La Sapienza|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Neuromed IRCCS|Swiss Federal Institute of Technology|Scripps Memorial Hospital|Global Brain Health Institute (GBHI)|Novartis|Research Center on Computational Biomarkers (RCCBM)|BiHELab - Bioinformatics and Human Electrophysiology Lab|Fundacion Clinic per a la Recerca Biomédica|Trinity College Dublin|University of Barcelona|SwissNeuroRadiologyInstitute (SNRI)","All","55 Years to 90 Years   (Adult, Older Adult)","Not Applicable","900","Industry|Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","altoidaML01","May 11, 2015","December 3, 2019","December 3, 2019","July 26, 2016",,"June 4, 2019",,,"https://ClinicalTrials.gov/show/NCT02843529"
58,"NCT03336411","A Personalized Diet Study to Reduce Glycemic Exposure",,"Recruiting","No Results Available","Pre-diabetes|Overweight and Obesity","Behavioral: mHealth|Behavioral: Personalized mHealth","Body weight, percent change|Body Composition|Metabolic Adaptation|Weight regain","NYU Langone Health|American Heart Association|Weizmann Institute of Science","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","17-00741","December 12, 2017","March 2020","September 2020","November 8, 2017",,"May 9, 2019","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03336411"
59,"NCT03379532","BCI-controlled NMES in Subacute Stroke",,"Recruiting","No Results Available","Stroke","Device: BCI-NMES|Device: Sham-NMES","Change in Upper Limb Fugl-Meyer Score, after treatment|Change in motor evoked potential amplitude of the paretic arm|Change in fractional anisotropy (FA) of the cortico-spinal tract as determined from diffusion tensor imaging|Change in electroencephalography functional connectivity","University Hospital, Geneva|Ecole Polytechnique Fédérale de Lausanne|Clinique Romande de Readaptation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","CRSII5-170985B","January 26, 2018","December 31, 2020","December 31, 2020","December 20, 2017",,"July 25, 2019","Division of Neurorehabilitation, University Hospital of Geneva, Geneva, GE, Switzerland|Clinique Romande de Readaptation, Sion, Switzerland",,"https://ClinicalTrials.gov/show/NCT03379532"
60,"NCT04039178","Efficacy of EMF BCI Based Device on Acute Stroke",,"Recruiting","No Results Available","Acute Stroke","Device: BQ|Device: Sham","Fugle Meyer (FM)|ARAT|BBT|TMT|NIHSS|Promis 10|MoCA|mRs|MRI-DTI|brain recovery biomarkers","BrainQ Technologies Ltd.","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","50","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BQ3","September 4, 2018","April 2020","June 2020","July 31, 2019",,"July 31, 2019","BLK super specialty hospital, New Delhi, India",,"https://ClinicalTrials.gov/show/NCT04039178"
61,"NCT03745118","Development of a Practical, Minimally Invasive Seizure Gauge",,"Enrolling by invitation","No Results Available","Epilepsy","Device: EpiTel EpiLog|Device: Byte Flies Sensor Dots|Device: Empatica E4|Device: Biovotion Everion|Device: GeneActiv","Assessment of Physiological Signals Measurable with Wearable Sensors|Pattern Analysis","Mayo Clinic","All","7 Years and older   (Child, Adult, Older Adult)","Not Applicable","80","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","18-008357","November 19, 2018","December 1, 2020","December 2020","November 19, 2018",,"January 10, 2019","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03745118"
62,"NCT03112928","Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP",,"Recruiting","No Results Available","Phantom Limb Pain","Device: Phantom Motor Execution|Device: Phantom Motor Imagery","Pain Rating Index registered at the beginning (1st session) and at the end of the treatment (15th session).|Pain Disability Index registered at the beginning (1st session) and the end of the treatment (15th session).","Integrum|Chalmers University of Technology|Sahlgrenska University Hospital, Sweden|Örebro University, Sweden|Bräcke Diakoni, Sweden|University Rehabilitation Institute, Republic of Slovenia|University Hospital, Ghent|University Medical Center Groningen|University of New Brunswick|National University of Ireland, Galway, Ireland|Ruhr University of Bochum","All","18 Years and older   (Adult, Older Adult)","Not Applicable","66","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","007733","May 8, 2017","April 2020","April 2020","April 13, 2017",,"August 7, 2019","Rehabilitation Centre Ghent University Hospital, Ghent, East Flanders, Belgium|Institue of Biomedical Engineering, University of New Brunswick, Fredericton, New Brunswick, Canada|School of Psychology, National University of Ireland, Galway, Connacht, Ireland|University of Groningen, University Medical Center Groningen, Department of Rehabilitation Medicine, Groningen, Netherlands|University Rehabilitation Institute, Ljubljana, Slovenia|Ortopedteknik, Region Örebro län, Örebro, Närke, Sweden|Bräcke Diakoni, Stockholm, Uppland, Sweden|Gåskolan, Ortopedtekniska avdelningen, Göteborg, Västergötland, Sweden",,"https://ClinicalTrials.gov/show/NCT03112928"
63,"NCT03882671","Development of a Minimally Invasive Seizure Gauge",,"Enrolling by invitation","No Results Available","Epilepsy","Device: EpiTel Epilog|Device: Empatica E4|Device: GENEActiv","Multimodal Assessment of Physiological Signals During Seizure Events Measurable with Wearable Sensors|Wearable Sensors Comfort Assessment|Seizure Detection and Prediction using Multimodal Physiological Data","Seer Medical Pty Ltd","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Industry","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HREC042_18","January 1, 2019","December 1, 2020","December 1, 2020","March 20, 2019",,"March 20, 2019","Seer Medical, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT03882671"
64,"NCT03896529","Neurobiological Mechanisms of Aging and Stress on Prospective Navigation",,"Recruiting","No Results Available","Aging|Anxiety|Memory Impairment","Behavioral: Anticipatory psychological stress","Behavioral probability of taking a shortcut between control and treatment groups|fMRI activation level between control and treatment groups|Neural memory representation reactivation between control and treatment groups|Relationship between fMRI activity level and behavioral probability of taking a shortcut.|2. Salivary cortisol (stress hormone) response difference between stress and control participant groups.","Georgia Institute of Technology","All","65 Years to 80 Years   (Older Adult)","Not Applicable","85","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H18233","April 15, 2019","October 1, 2020","March 31, 2021","April 1, 2019",,"July 22, 2019","Center for Advance Brain Imaging, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT03896529"
65,"NCT03785028","Analysis of Electrocorticographic Signals",,"Recruiting","No Results Available","Epilepsy","Behavioral: working memory and attention","Experiment 1.b. Prioritization cue-related changes in the neural representation of stimuli|Experiment 1.b. Prioritization cue-related changes in phase-amplitude coupling|Experiment 3.b. Covert spatial attention-related changes in phase-amplitude coupling","University of Wisconsin, Madison","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015-0282","July 19, 2019","December 2023","December 2023","December 24, 2018",,"August 5, 2019","University of Wisconsin, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03785028"
66,"NCT02641145","Molecular Imaging of Primary Amyloid Cardiomyopathy","MICA","Recruiting","No Results Available","Amyloidosis, Primary|Cardiomyopathy","Radiation: F-18 florbetapir/C-11 acetate PET|Device: MRI|Radiation: N-13 ammonia PET","Change in F-18 florbetapir myocardial retention index from baseline to 6 months and 12 months|Change in Serum oxidative stress markers from baseline to 6 months and 12 months|Change in Myocardial oxidative metabolism markers from baseline to 6 months|Change in Magnetic resonance imaging markers from baseline to 6 months and 12 months|Change in Myocardial energy efficiency from baseline to 6 months|Light Chain Toxicity|Understand the role of gut microbiota and heavy metals in the pathogenesis of AL Amyloidosis","Brigham and Women's Hospital|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)|American Heart Association","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","125","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2015P002477|1R01HL130563-01A1","April 1, 2016","March 30, 2020","April 2020","December 29, 2015",,"August 2, 2019","Brigham and Womens' Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02641145"
67,"NCT03979573","Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer","PROMM-AS","Recruiting","No Results Available","Prostate Cancer","Diagnostic Test: Multiparametric MRI|Diagnostic Test: Radiomics|Diagnostic Test: MR-guided Biopsy|Diagnostic Test: Molecular Markers","Reduction of the discontinuation of Active Surveillance (AS)|Value of MRI (ADC) regarding aggressiveness|Detectionrates of targeted (FUS-GB) versus systematic (TRUS-GB) biopsies|Correlation of clinical parameters with Gleason score progression or MRI quantified progression|Patient compliance to recommended MRI-based observation|Evaluation of Resolve DWI","Heinrich-Heine University, Duesseldorf","Male","Child, Adult, Older Adult","Not Applicable","90","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","5941R","October 1, 2017","September 30, 2020","September 30, 2021","June 7, 2019",,"June 7, 2019","University Düsseldorf, Medical Faculty, Dusseldorf, NRW, Germany",,"https://ClinicalTrials.gov/show/NCT03979573"
68,"NCT03530098","Validation of an Artificial Intelligence-based Algorithm for Skeletal Age Assessment",,"Active, not recruiting","No Results Available","Bone Age","Device: BoneAgeModel","Paired Difference of Skeletal Age Estimate|Time Saved","Stanford University","All","1 Year to 18 Years   (Child, Adult)","Not Applicable","2100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRB #44764","July 12, 2018","September 2019","September 2019","May 21, 2018",,"August 12, 2019","Stanford University, Stanford, California, United States|Yale New Haven Hospital, New Haven, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Emory University, Atlanta, Georgia, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Boston Children's Hospital, Boston, Massachusetts, United States|New York University, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03530098"
69,"NCT02556567","Exploring the Effects of Sleep Patterns and Physical Activity on Asthma in Adolescents With Wrist-worn Smart Devices",,"Completed","No Results Available","Asthma","Other: Fitbit® Charge Heart Rate (HR) wristband","Asthma Symptoms , Sleep Patterns and Physical Activity|Risk of Increasing Asthma Symptoms","Arkansas Children's Hospital Research Institute|University of Arkansas|University of Florida","All","14 Years to 17 Years   (Child)","Not Applicable","23","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","204310","August 2015","June 2016","December 2016","September 22, 2015",,"June 28, 2018","Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States",,"https://ClinicalTrials.gov/show/NCT02556567"
70,"NCT01775826","Validating Machine -Learned Classifiers of Sedentary Behavior and Physical Activity","iWatch","Completed","No Results Available","Physical Activity|Sedentary Lifestyle","Other: Measurement","physical activity behavior classification using study sensors (accelerometers, Sensecam and GPS)","University of California, San Diego","All","6 Years to 85 Years   (Child, Adult, Older Adult)","Not Applicable","225","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1R01CA164993-01A1","March 2013","April 2016","April 2016","January 25, 2013",,"August 20, 2019","UCSD, La Jolla, California, United States",,"https://ClinicalTrials.gov/show/NCT01775826"
71,"NCT03419520","GENYAL Study to Childhood Obesity Prevention",,"Completed","No Results Available","Childhood Onset Obesity","Behavioral: Nutritional counseling","Changes in the percentage of children with a diagnosis of obesity|Changes in energy intake|Changes in body fat mass percentage|Physical activity|Genetic predisposition to develop obesity","IMDEA Food","All","6 Years to 7 Years   (Child)","Not Applicable","221","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","IMD PI0024","February 15, 2017","March 30, 2017","March 30, 2017","February 2, 2018",,"August 13, 2019","IMDEA-Food, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT03419520"
72,"NCT03569176","Examining the Efficacy of a Mobile Therapy for Children With Autism Spectrum Disorder",,"Completed","No Results Available","Autism Spectrum Disorder","Device: Autism Glass","Change in socialization subscale scores of the Vineland Adaptive Behavior Scales, 2nd Edition (VABS-II) from baseline to week 6.|Change in Parent Rated Social Responsiveness Scale 2 (SRS-2) from baseline to week 6|Change in NEPSY-II, Affect Recognition subscale scores from baseline to week 6|Change in Emotion Guessing Game (EGG) scores from baseline to week 6|Change in ASD symptoms as measured by Brief Observation of Social Communication Change (BOSCC) from baseline to week 6|Change in adaptive social and personal skills as measured by Vineland Adaptive Behavior Scales, 2nd edition (VABS-II) Full Scale from baseline to week 6.|Change in child's emotional, behavioral, and social problems from Baseline (week 0) to Week 6 as measured by Child Behavior Checklist (CBCL).","Dennis Paul Wall|Stanford University","All","6 Years to 12 Years   (Child)","Not Applicable","74","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IRB-34059","November 1, 2016","April 11, 2018","April 15, 2018","June 26, 2018",,"July 17, 2018",,,"https://ClinicalTrials.gov/show/NCT03569176"
73,"NCT03422770","Ultrasonic Markers for Myocardial Fibrosis and Prognosis in Aortic Stenosis",,"Recruiting","No Results Available","Aortic Valve Stenosis|Myocardial Fibrosis","Diagnostic Test: Echocardiography|Diagnostic Test: MRI|Diagnostic Test: Blood test|Diagnostic Test: ECG and Holter-ECG|Diagnostic Test: 6 min walking test","Cardiovascular morbidity and mortality|All cause mortality|Time of first re-hospitalisation|Cardiac systolic function|Cardiac diastolic function","Norwegian University of Science and Technology|St. Olavs Hospital|Oslo University Hospital","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","2017/1068","January 9, 2018","January 2031","January 2031","February 6, 2018",,"February 1, 2019","Department of Circulation and Medical Imaging, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT03422770"
74,"NCT03800329","Remote Monitoring to Improve Physician Monitoring, Patient Satisfaction, and Predict Readmissions Following Surgery",,"Enrolling by invitation","No Results Available","Remote Monitoring","Device: Snap40 Monitor|Other: No Monitor","Physician satisfaction in the use of remote monitoring technology.|Patient satisfaction in the use of remote monitoring technology.","Mayo Clinic|Snap40 Ltd.","All","40 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","17-008249","March 7, 2018","March 2020","March 2020","January 11, 2019",,"January 11, 2019","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03800329"
75,"NCT03773562","Imaging the Migraine Brain Pre- and Post-Erenumab",,"Recruiting","No Results Available","Migraine","Drug: Erenumab","Changes in Pain-Induced Brain Activations|Changes in Brain Functional Connectivity (temporal correlations in BOLD signal fluctuations)|Accuracy of Predicting Treatment Response|Early Changes in Pain-Induced Brain Activations|Early Changes in Brain Functional Connectivity (temporal correlations in BOLD signal fluctuations)|Changes in Brain Perfusion|Changes in Brain Regional Volumes|Changes in Brain Cortical Thickness|Changes in Brain White Matter Tract Integrity","Mayo Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","50","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-001497","March 25, 2019","September 3, 2020","December 2, 2020","December 12, 2018",,"April 5, 2019","Mayo Clinic in Arizona, Scottsdale, Arizona, United States",,"https://ClinicalTrials.gov/show/NCT03773562"
76,"NCT03623828","Treating Severe Brain-injured Patients With Apomorphine",,"Recruiting","No Results Available","Disorder of Consciousness","Drug: Apomorphine Hydrochloride 50Mg/10mL Prefilled Syringe","Change from baseline in Coma Recovery Scale - Revised (CRS-R)|Nociception Coma Scale - Revised (NCS-R)|resting-state EEG|EEG with auditory paradigms|PET|fMRI|Circadian rythmycity using body movements|Circadian rythmycity using body temperature variations|Number of sleep cycles using night EEG|Glasgow Outcome Scale - Extended (GOS-E)|Phone-adapted CRS-R","University of Liege|Université Catholique de Louvain","All","18 Years to 55 Years   (Adult)","Phase 2","6","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2017/81a","September 15, 2018","October 2019","August 2021","August 9, 2018",,"August 9, 2018","Neurological Hospital Center William Lennox, Ottignies, Brabant Wallon, Belgium|University Hospital of Liège, Liège, Belgium",,"https://ClinicalTrials.gov/show/NCT03623828"
77,"NCT03787134","Oscillatory Contributions to Working Memory and Attention",,"Recruiting","No Results Available","Young Adults","Behavioral: working memory and attention","Experiment 1.a. Behavioral accuracy|Experiment 1.a. Reaction time|Experiment 1.a. Changes in multivariate pattern classification of electroencephalography data in response to prioritization cues and in response to pulses of transcranial magnetic stimulation.|Experiment 1.a. Spatially distributed phase coupling extraction-identified components of the transcranial magnetic stimulation-evoked electroencephalography signal|Experiment 2.a. The amplitude of multivariate inverted encoding model-reconstructions of stimulus location, derived from the transcranial magnetic stimulation-evoked response|Experiment 2.a. Spatially distributed phase coupling extraction-identified components of the transcranial magnetic stimulation-evoked electroencephalography signal|Experiment 2.a. Correlation of the amplitude of multivariate inverted encoding model-reconstructions of the location of the unattended memory item with alpha band power.|Experiment 2.a. Correlation of the amplitude of multivariate inverted encoding model-reconstructions of the location of the unattended memory item with beta-band power|Experiment 3.a. Power in the alpha band of the EEG as a function of retinotopic location|Experiment 3.a. Frequency in the alpha band of the EEG as a function of retinotopic location|Experiment 3.a. Spatially distributed phase coupling extraction-identified components of the electroencephalography signal from signals corresponding to the attended location|Experiment 4.a. Behavioral accuracy assessed as mean percentage correct responses.|Experiment 4.a. Reaction time assess as latency to press response button after onset of critical stimulus.|Experiment 4.a. Power in the alpha band of the EEG as a function of retinotopic location|Experiment 4.a. Frequency in the alpha band of the EEG as a function of retinotopic location|Experiment 4.a. Spatially distributed phase coupling extraction-identified alpha-band components of the electroencephalography signal from signals corresponding to the attended location|Experiment 5. The amplitude of the ""contralateral delay activity"" (CDA) slow component of the EEG during the time period from 1000-1600 milliseconds after stimulus array onset.|Experiment 5. Multivariate inverted encoding modeling of the EEG signal to determine whether or not stimulus information is carried in this signal.|Experiment 6. Multivariate inverted encoding modeling of the EEG signal to determine whether or not contextual information is carried in this signal","University of Wisconsin, Madison","All","18 Years to 35 Years   (Adult)","Not Applicable","269","Other","Interventional","Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2016-0500","March 1, 2019","December 2023","December 2023","December 25, 2018",,"April 24, 2019","University of Wisconsin - Madison, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03787134"
